EuBiologics Co., Ltd. (206650.KQ)
KRW 12130.0
(-3.58%)
KRW 12130.0
(-3.58%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -13.87 Billion KRW | -1163.04% |
| 2022 | -1.09 Billion KRW | 96.01% |
| 2021 | -27.57 Billion KRW | 54.15% |
| 2020 | -60.13 Billion KRW | -6720.88% |
| 2019 | -881.62 Million KRW | -123.32% |
| 2018 | 3.78 Billion KRW | 180.18% |
| 2017 | -4.71 Billion KRW | 29.65% |
| 2016 | -6.7 Billion KRW | -137.0% |
| 2015 | -2.82 Billion KRW | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -3.61 Billion KRW | 71.55% |
| 2024 Q2 | -1.59 Billion KRW | 56.01% |
| 2023 Q3 | -3.1 Billion KRW | -252.2% |
| 2023 Q2 | 2.03 Billion KRW | 2022.59% |
| 2023 FY | -13.87 Billion KRW | -1163.04% |
| 2023 Q1 | -105.99 Million KRW | 96.68% |
| 2023 Q4 | -12.7 Billion KRW | -309.76% |
| 2022 Q1 | 118.41 Million KRW | 268.2% |
| 2022 FY | -1.09 Billion KRW | 96.01% |
| 2022 Q3 | 249.56 Million KRW | -85.53% |
| 2022 Q2 | 1.72 Billion KRW | 1356.37% |
| 2022 Q4 | -3.19 Billion KRW | -1378.78% |
| 2021 Q3 | 2.03 Billion KRW | 107.67% |
| 2021 Q1 | -2.99 Billion KRW | 0.0% |
| 2021 FY | -27.57 Billion KRW | 54.15% |
| 2021 Q2 | -26.54 Billion KRW | -786.66% |
| 2021 Q4 | -70.39 Million KRW | -103.46% |
| 2020 FY | -60.13 Billion KRW | -6720.88% |
| 2019 FY | -881.62 Million KRW | -123.32% |
| 2018 FY | 3.78 Billion KRW | 180.18% |
| 2017 FY | -4.71 Billion KRW | 29.65% |
| 2016 FY | -6.7 Billion KRW | -137.0% |
| 2015 FY | -2.82 Billion KRW | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| HLB Pharmaceutical Co., Ltd | -19.42 Billion KRW | 28.56% |
| CMG Pharmaceutical Co., Ltd. | 6.45 Billion KRW | 315.0% |
| Celltrion Pharm, Inc. | 21.26 Billion KRW | 165.267% |
| Huons Global Co., Ltd. | 38.38 Billion KRW | 136.159% |
| DongKook Pharmaceutical Co., Ltd. | 47.17 Billion KRW | 129.42% |
| Enzychem Lifesciences Corporation | -9.32 Billion KRW | -48.814% |
| Humedix Co., Ltd. | 24.82 Billion KRW | 155.917% |
| Boditech Med Inc. | 25.94 Billion KRW | 153.49% |
| FutureChem Co.,Ltd | -6.7 Billion KRW | -106.873% |
| Huons Co., Ltd. | 50.47 Billion KRW | 127.498% |
| BNC Korea Co., Ltd. | 25.68 Billion KRW | 154.033% |
| AptaBio Therapeutics Inc. | -12.06 Billion KRW | -15.067% |